News

The winners of the Best Scientific Image Contest 2019 have been announced. Here you can see the best pictures.

Cancer researcher and conceptual artist Anton Henssen opens his first solo exhibition in Berlin on June 6. In the Alte Münze, the children's oncologe presents works in which he deals with circular DNA.

An international team of researchers are seeking to explore the heart at a depth that was previously impossible. They have now received a grant of nearly four million US dollars from the Chan Zuckerberg Initiative – as one of the 38 Seed Networks working on the Human Cell Atlas. MDC researcher Norbert Hübner is co-coordinator of the project.

In late May, some 350 scientists met at the MDC for the 10th Brain Tumor Meeting. The president of this conference series, Professor Helmut Kettenmann, recounts the event’s highlights and explains why brain tumor research needs to differentiate between men and women.

The artist Emilia Tikka spent three months as a guest in the MDC labs to gather inspiration for her work “ÆON. Trajectories of Longevity and CRISPR.”

Leslie Leinwand, a distinguished professor at University of Colorado Boulder and co-founder of three biotech companies, will give a lecture at MDC on June 17 about her work on the inherited heart disease that kills young athletes, and taking potential therapies from the lab to clinical trials.

A team led by Professor Norbert Hübner’s MDC research group has observed the human heart cells’ “protein factories” in action, examining the entire tissue for the very first time. In an article published in Cell, the group reveals their surprising discoveries and the possibilities they contain for the future treatment of heart disease.

Although classical Hodgkin’s lymphoma is generally easily treatable today, many aspects of the disease still remain a mystery. A team at the MDC led by Professor Claus Scheidereit has now identified an important signaling molecule in the biology of this lymphoma: LTA.

In late April, the Berlin-North study center at the MDC welcomed its 10,000th subject in the GNC health study. This completes the first round of baseline examinations.

Anton Henssen specializes in rare tumors in children. As the new group leader at the Experimental and Clinical Research Center (ECRC), the physician hopes to contribute to ensuring that the knowledge gained in cancer research benefits patients as quickly as possible.